nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—Cladribine—multiple sclerosis	0.546	1	CrCtD
Floxuridine—TYMS—Methotrexate—multiple sclerosis	0.0809	1	CbGbCtD
Floxuridine—Trifluridine—Cladribine—multiple sclerosis	0.0746	0.224	CrCrCtD
Floxuridine—Idoxuridine—Cladribine—multiple sclerosis	0.0746	0.224	CrCrCtD
Floxuridine—Telbivudine—Cladribine—multiple sclerosis	0.0746	0.224	CrCrCtD
Floxuridine—Pentostatin—Cladribine—multiple sclerosis	0.0679	0.204	CrCrCtD
Floxuridine—Decitabine—Cladribine—multiple sclerosis	0.0408	0.123	CrCrCtD
Floxuridine—Cladribine—RRM1—multiple sclerosis	0.000692	0.864	CrCbGaD
Floxuridine—Ill-defined disorder—Cladribine—multiple sclerosis	0.000177	0.00484	CcSEcCtD
Floxuridine—Anaemia—Cladribine—multiple sclerosis	0.000176	0.00482	CcSEcCtD
Floxuridine—Headache—Fingolimod—multiple sclerosis	0.000172	0.00471	CcSEcCtD
Floxuridine—Malaise—Cladribine—multiple sclerosis	0.000172	0.0047	CcSEcCtD
Floxuridine—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000171	0.00467	CcSEcCtD
Floxuridine—Euphoric mood—Betamethasone—multiple sclerosis	0.000169	0.00461	CcSEcCtD
Floxuridine—Euphoric mood—Dexamethasone—multiple sclerosis	0.000169	0.00461	CcSEcCtD
Floxuridine—Thrombophlebitis—Betamethasone—multiple sclerosis	0.000164	0.0045	CcSEcCtD
Floxuridine—Thrombophlebitis—Dexamethasone—multiple sclerosis	0.000164	0.0045	CcSEcCtD
Floxuridine—Discomfort—Cladribine—multiple sclerosis	0.00016	0.00439	CcSEcCtD
Floxuridine—Alopecia—Azathioprine—multiple sclerosis	0.000157	0.00431	CcSEcCtD
Floxuridine—Confusional state—Cladribine—multiple sclerosis	0.000157	0.00429	CcSEcCtD
Floxuridine—Dry skin—Prednisolone—multiple sclerosis	0.000156	0.00428	CcSEcCtD
Floxuridine—Stomatitis—Mitoxantrone—multiple sclerosis	0.000156	0.00428	CcSEcCtD
Floxuridine—Glossitis—Methotrexate—multiple sclerosis	0.000155	0.00424	CcSEcCtD
Floxuridine—Infection—Cladribine—multiple sclerosis	0.000154	0.00423	CcSEcCtD
Floxuridine—Nervous system disorder—Cladribine—multiple sclerosis	0.000152	0.00418	CcSEcCtD
Floxuridine—Thrombocytopenia—Cladribine—multiple sclerosis	0.000152	0.00417	CcSEcCtD
Floxuridine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00015	0.00409	CcSEcCtD
Floxuridine—Anorexia—Cladribine—multiple sclerosis	0.000148	0.00406	CcSEcCtD
Floxuridine—Euphoric mood—Prednisone—multiple sclerosis	0.000147	0.00402	CcSEcCtD
Floxuridine—Lethargy—Dexamethasone—multiple sclerosis	0.000145	0.00398	CcSEcCtD
Floxuridine—Lethargy—Betamethasone—multiple sclerosis	0.000145	0.00398	CcSEcCtD
Floxuridine—Haemoglobin—Mitoxantrone—multiple sclerosis	0.000145	0.00396	CcSEcCtD
Floxuridine—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000144	0.00394	CcSEcCtD
Floxuridine—Ill-defined disorder—Azathioprine—multiple sclerosis	0.000144	0.00394	CcSEcCtD
Floxuridine—Thrombophlebitis—Prednisone—multiple sclerosis	0.000143	0.00392	CcSEcCtD
Floxuridine—Anaemia—Azathioprine—multiple sclerosis	0.000143	0.00392	CcSEcCtD
Floxuridine—Pharyngitis—Mitoxantrone—multiple sclerosis	0.000143	0.00391	CcSEcCtD
Floxuridine—Malaise—Azathioprine—multiple sclerosis	0.00014	0.00383	CcSEcCtD
Floxuridine—Leukopenia—Azathioprine—multiple sclerosis	0.000139	0.0038	CcSEcCtD
Floxuridine—Decreased appetite—Cladribine—multiple sclerosis	0.000135	0.0037	CcSEcCtD
Floxuridine—Dry skin—Dexamethasone—multiple sclerosis	0.00013	0.00357	CcSEcCtD
Floxuridine—Dry skin—Betamethasone—multiple sclerosis	0.00013	0.00357	CcSEcCtD
Floxuridine—Discomfort—Azathioprine—multiple sclerosis	0.00013	0.00357	CcSEcCtD
Floxuridine—Feeling abnormal—Cladribine—multiple sclerosis	0.000128	0.00351	CcSEcCtD
Floxuridine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000127	0.00348	CcSEcCtD
Floxuridine—Alopecia—Mitoxantrone—multiple sclerosis	0.000127	0.00348	CcSEcCtD
Floxuridine—Lethargy—Prednisone—multiple sclerosis	0.000127	0.00346	CcSEcCtD
Floxuridine—Infection—Azathioprine—multiple sclerosis	0.000126	0.00344	CcSEcCtD
Floxuridine—Erythema—Mitoxantrone—multiple sclerosis	0.000125	0.00343	CcSEcCtD
Floxuridine—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000124	0.00339	CcSEcCtD
Floxuridine—Body temperature increased—Cladribine—multiple sclerosis	0.000123	0.00337	CcSEcCtD
Floxuridine—Abdominal pain—Cladribine—multiple sclerosis	0.000123	0.00337	CcSEcCtD
Floxuridine—Thrombophlebitis—Methotrexate—multiple sclerosis	0.00012	0.00328	CcSEcCtD
Floxuridine—Haemoglobin—Prednisolone—multiple sclerosis	0.000119	0.00325	CcSEcCtD
Floxuridine—Haemorrhage—Prednisolone—multiple sclerosis	0.000118	0.00323	CcSEcCtD
Floxuridine—Photosensitivity—Methotrexate—multiple sclerosis	0.000118	0.00323	CcSEcCtD
Floxuridine—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000116	0.00318	CcSEcCtD
Floxuridine—Anaemia—Mitoxantrone—multiple sclerosis	0.000116	0.00317	CcSEcCtD
Floxuridine—TYMP—medulla oblongata—multiple sclerosis	0.000115	0.115	CbGeAlD
Floxuridine—Hypersensitivity—Cladribine—multiple sclerosis	0.000115	0.00314	CcSEcCtD
Floxuridine—Epistaxis—Triamcinolone—multiple sclerosis	0.000114	0.00312	CcSEcCtD
Floxuridine—Dry skin—Prednisone—multiple sclerosis	0.000114	0.00311	CcSEcCtD
Floxuridine—Malaise—Mitoxantrone—multiple sclerosis	0.000113	0.00309	CcSEcCtD
Floxuridine—Leukopenia—Mitoxantrone—multiple sclerosis	0.000112	0.00307	CcSEcCtD
Floxuridine—Asthenia—Cladribine—multiple sclerosis	0.000112	0.00305	CcSEcCtD
Floxuridine—Zidovudine—ALB—multiple sclerosis	0.000109	0.136	CrCbGaD
Floxuridine—Haemoglobin—Triamcinolone—multiple sclerosis	0.000109	0.00299	CcSEcCtD
Floxuridine—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000109	0.00298	CcSEcCtD
Floxuridine—Haemorrhage—Triamcinolone—multiple sclerosis	0.000109	0.00297	CcSEcCtD
Floxuridine—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000108	0.00297	CcSEcCtD
Floxuridine—Pharyngitis—Triamcinolone—multiple sclerosis	0.000108	0.00295	CcSEcCtD
Floxuridine—Diarrhoea—Cladribine—multiple sclerosis	0.000106	0.00291	CcSEcCtD
Floxuridine—Lethargy—Methotrexate—multiple sclerosis	0.000106	0.00289	CcSEcCtD
Floxuridine—Discomfort—Mitoxantrone—multiple sclerosis	0.000105	0.00288	CcSEcCtD
Floxuridine—TYMP—midbrain—multiple sclerosis	0.000105	0.105	CbGeAlD
Floxuridine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000104	0.00285	CcSEcCtD
Floxuridine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000103	0.00283	CcSEcCtD
Floxuridine—Confusional state—Mitoxantrone—multiple sclerosis	0.000103	0.00282	CcSEcCtD
Floxuridine—Erythema—Prednisolone—multiple sclerosis	0.000103	0.00281	CcSEcCtD
Floxuridine—TYMP—spinal cord—multiple sclerosis	0.000103	0.102	CbGeAlD
Floxuridine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000102	0.0028	CcSEcCtD
Floxuridine—Infection—Mitoxantrone—multiple sclerosis	0.000102	0.00278	CcSEcCtD
Floxuridine—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.0001	0.00274	CcSEcCtD
Floxuridine—Body temperature increased—Azathioprine—multiple sclerosis	0.0001	0.00274	CcSEcCtD
Floxuridine—Abdominal pain—Azathioprine—multiple sclerosis	0.0001	0.00274	CcSEcCtD
Floxuridine—Haemoglobin—Betamethasone—multiple sclerosis	9.9e-05	0.00271	CcSEcCtD
Floxuridine—Haemoglobin—Dexamethasone—multiple sclerosis	9.9e-05	0.00271	CcSEcCtD
Floxuridine—Vomiting—Cladribine—multiple sclerosis	9.89e-05	0.00271	CcSEcCtD
Floxuridine—Haemorrhage—Betamethasone—multiple sclerosis	9.85e-05	0.0027	CcSEcCtD
Floxuridine—Haemorrhage—Dexamethasone—multiple sclerosis	9.85e-05	0.0027	CcSEcCtD
Floxuridine—Rash—Cladribine—multiple sclerosis	9.8e-05	0.00268	CcSEcCtD
Floxuridine—Dermatitis—Cladribine—multiple sclerosis	9.8e-05	0.00268	CcSEcCtD
Floxuridine—Anorexia—Mitoxantrone—multiple sclerosis	9.74e-05	0.00267	CcSEcCtD
Floxuridine—Headache—Cladribine—multiple sclerosis	9.74e-05	0.00267	CcSEcCtD
Floxuridine—Ill-defined disorder—Prednisolone—multiple sclerosis	9.53e-05	0.00261	CcSEcCtD
Floxuridine—Erythema—Triamcinolone—multiple sclerosis	9.45e-05	0.00259	CcSEcCtD
Floxuridine—Erythema—Methylprednisolone—multiple sclerosis	9.43e-05	0.00258	CcSEcCtD
Floxuridine—TYMS—Azacitidine—Cladribine—multiple sclerosis	9.42e-05	0.0491	CbGdCrCtD
Floxuridine—Hypersensitivity—Azathioprine—multiple sclerosis	9.32e-05	0.00255	CcSEcCtD
Floxuridine—Malaise—Prednisolone—multiple sclerosis	9.27e-05	0.00254	CcSEcCtD
Floxuridine—Nausea—Cladribine—multiple sclerosis	9.24e-05	0.00253	CcSEcCtD
Floxuridine—TYMS—midbrain—multiple sclerosis	9.01e-05	0.09	CbGeAlD
Floxuridine—Decreased appetite—Mitoxantrone—multiple sclerosis	8.89e-05	0.00243	CcSEcCtD
Floxuridine—Ill-defined disorder—Triamcinolone—multiple sclerosis	8.77e-05	0.0024	CcSEcCtD
Floxuridine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	8.75e-05	0.00239	CcSEcCtD
Floxuridine—Alopecia—Betamethasone—multiple sclerosis	8.7e-05	0.00238	CcSEcCtD
Floxuridine—Alopecia—Dexamethasone—multiple sclerosis	8.7e-05	0.00238	CcSEcCtD
Floxuridine—Diarrhoea—Azathioprine—multiple sclerosis	8.65e-05	0.00237	CcSEcCtD
Floxuridine—Discomfort—Prednisolone—multiple sclerosis	8.64e-05	0.00237	CcSEcCtD
Floxuridine—TYMP—nervous system—multiple sclerosis	8.64e-05	0.0862	CbGeAlD
Floxuridine—Haemoglobin—Prednisone—multiple sclerosis	8.62e-05	0.00236	CcSEcCtD
Floxuridine—Haemorrhage—Prednisone—multiple sclerosis	8.58e-05	0.00235	CcSEcCtD
Floxuridine—Erythema—Betamethasone—multiple sclerosis	8.57e-05	0.00235	CcSEcCtD
Floxuridine—Erythema—Dexamethasone—multiple sclerosis	8.57e-05	0.00235	CcSEcCtD
Floxuridine—Malaise—Triamcinolone—multiple sclerosis	8.52e-05	0.00233	CcSEcCtD
Floxuridine—Pancytopenia—Methotrexate—multiple sclerosis	8.5e-05	0.00233	CcSEcCtD
Floxuridine—Malaise—Methylprednisolone—multiple sclerosis	8.5e-05	0.00233	CcSEcCtD
Floxuridine—Feeling abnormal—Mitoxantrone—multiple sclerosis	8.42e-05	0.00231	CcSEcCtD
Floxuridine—Anaphylactic shock—Prednisolone—multiple sclerosis	8.39e-05	0.0023	CcSEcCtD
Floxuridine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	8.36e-05	0.00229	CcSEcCtD
Floxuridine—TYMP—central nervous system—multiple sclerosis	8.32e-05	0.083	CbGeAlD
Floxuridine—Photosensitivity reaction—Methotrexate—multiple sclerosis	8.17e-05	0.00224	CcSEcCtD
Floxuridine—TYMP—cerebellum—multiple sclerosis	8.13e-05	0.0812	CbGeAlD
Floxuridine—Abdominal pain—Mitoxantrone—multiple sclerosis	8.08e-05	0.00221	CcSEcCtD
Floxuridine—Body temperature increased—Mitoxantrone—multiple sclerosis	8.08e-05	0.00221	CcSEcCtD
Floxuridine—Vomiting—Azathioprine—multiple sclerosis	8.04e-05	0.0022	CcSEcCtD
Floxuridine—Rash—Azathioprine—multiple sclerosis	7.97e-05	0.00218	CcSEcCtD
Floxuridine—Dermatitis—Azathioprine—multiple sclerosis	7.96e-05	0.00218	CcSEcCtD
Floxuridine—Ill-defined disorder—Betamethasone—multiple sclerosis	7.95e-05	0.00218	CcSEcCtD
Floxuridine—Ill-defined disorder—Dexamethasone—multiple sclerosis	7.95e-05	0.00218	CcSEcCtD
Floxuridine—Discomfort—Triamcinolone—multiple sclerosis	7.95e-05	0.00218	CcSEcCtD
Floxuridine—Discomfort—Methylprednisolone—multiple sclerosis	7.93e-05	0.00217	CcSEcCtD
Floxuridine—Headache—Azathioprine—multiple sclerosis	7.92e-05	0.00217	CcSEcCtD
Floxuridine—Stomatitis—Methotrexate—multiple sclerosis	7.78e-05	0.00213	CcSEcCtD
Floxuridine—Confusional state—Methylprednisolone—multiple sclerosis	7.76e-05	0.00212	CcSEcCtD
Floxuridine—Malaise—Betamethasone—multiple sclerosis	7.73e-05	0.00212	CcSEcCtD
Floxuridine—Malaise—Dexamethasone—multiple sclerosis	7.73e-05	0.00212	CcSEcCtD
Floxuridine—Anaphylactic shock—Triamcinolone—multiple sclerosis	7.71e-05	0.00211	CcSEcCtD
Floxuridine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	7.69e-05	0.00211	CcSEcCtD
Floxuridine—Infection—Triamcinolone—multiple sclerosis	7.66e-05	0.0021	CcSEcCtD
Floxuridine—Infection—Methylprednisolone—multiple sclerosis	7.64e-05	0.00209	CcSEcCtD
Floxuridine—Alopecia—Prednisone—multiple sclerosis	7.58e-05	0.00208	CcSEcCtD
Floxuridine—Nervous system disorder—Methylprednisolone—multiple sclerosis	7.55e-05	0.00207	CcSEcCtD
Floxuridine—Epistaxis—Methotrexate—multiple sclerosis	7.53e-05	0.00206	CcSEcCtD
Floxuridine—Hypersensitivity—Mitoxantrone—multiple sclerosis	7.53e-05	0.00206	CcSEcCtD
Floxuridine—Nausea—Azathioprine—multiple sclerosis	7.51e-05	0.00206	CcSEcCtD
Floxuridine—Erythema—Prednisone—multiple sclerosis	7.47e-05	0.00204	CcSEcCtD
Floxuridine—Agranulocytosis—Methotrexate—multiple sclerosis	7.45e-05	0.00204	CcSEcCtD
Floxuridine—TYMS—nervous system—multiple sclerosis	7.41e-05	0.074	CbGeAlD
Floxuridine—Asthenia—Mitoxantrone—multiple sclerosis	7.33e-05	0.00201	CcSEcCtD
Floxuridine—Discomfort—Dexamethasone—multiple sclerosis	7.21e-05	0.00197	CcSEcCtD
Floxuridine—Discomfort—Betamethasone—multiple sclerosis	7.21e-05	0.00197	CcSEcCtD
Floxuridine—Haemoglobin—Methotrexate—multiple sclerosis	7.2e-05	0.00197	CcSEcCtD
Floxuridine—Haemorrhage—Methotrexate—multiple sclerosis	7.17e-05	0.00196	CcSEcCtD
Floxuridine—TYMS—central nervous system—multiple sclerosis	7.13e-05	0.0712	CbGeAlD
Floxuridine—Pharyngitis—Methotrexate—multiple sclerosis	7.11e-05	0.00195	CcSEcCtD
Floxuridine—Anaphylactic shock—Dexamethasone—multiple sclerosis	7e-05	0.00192	CcSEcCtD
Floxuridine—Anaphylactic shock—Betamethasone—multiple sclerosis	7e-05	0.00192	CcSEcCtD
Floxuridine—Diarrhoea—Mitoxantrone—multiple sclerosis	6.99e-05	0.00191	CcSEcCtD
Floxuridine—TYMS—cerebellum—multiple sclerosis	6.97e-05	0.0696	CbGeAlD
Floxuridine—Infection—Betamethasone—multiple sclerosis	6.95e-05	0.0019	CcSEcCtD
Floxuridine—Infection—Dexamethasone—multiple sclerosis	6.95e-05	0.0019	CcSEcCtD
Floxuridine—Ill-defined disorder—Prednisone—multiple sclerosis	6.93e-05	0.0019	CcSEcCtD
Floxuridine—Feeling abnormal—Prednisolone—multiple sclerosis	6.91e-05	0.00189	CcSEcCtD
Floxuridine—Anaemia—Prednisone—multiple sclerosis	6.9e-05	0.00189	CcSEcCtD
Floxuridine—Nervous system disorder—Dexamethasone—multiple sclerosis	6.86e-05	0.00188	CcSEcCtD
Floxuridine—Nervous system disorder—Betamethasone—multiple sclerosis	6.86e-05	0.00188	CcSEcCtD
Floxuridine—Thrombocytopenia—Betamethasone—multiple sclerosis	6.85e-05	0.00188	CcSEcCtD
Floxuridine—Thrombocytopenia—Dexamethasone—multiple sclerosis	6.85e-05	0.00188	CcSEcCtD
Floxuridine—Malaise—Prednisone—multiple sclerosis	6.73e-05	0.00184	CcSEcCtD
Floxuridine—Anorexia—Betamethasone—multiple sclerosis	6.67e-05	0.00183	CcSEcCtD
Floxuridine—Anorexia—Dexamethasone—multiple sclerosis	6.67e-05	0.00183	CcSEcCtD
Floxuridine—TYMP—brain—multiple sclerosis	6.6e-05	0.0659	CbGeAlD
Floxuridine—Vomiting—Mitoxantrone—multiple sclerosis	6.5e-05	0.00178	CcSEcCtD
Floxuridine—Rash—Mitoxantrone—multiple sclerosis	6.44e-05	0.00176	CcSEcCtD
Floxuridine—Dermatitis—Mitoxantrone—multiple sclerosis	6.44e-05	0.00176	CcSEcCtD
Floxuridine—Headache—Mitoxantrone—multiple sclerosis	6.4e-05	0.00175	CcSEcCtD
Floxuridine—Feeling abnormal—Triamcinolone—multiple sclerosis	6.35e-05	0.00174	CcSEcCtD
Floxuridine—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.34e-05	0.00174	CcSEcCtD
Floxuridine—Alopecia—Methotrexate—multiple sclerosis	6.33e-05	0.00173	CcSEcCtD
Floxuridine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.29e-05	0.00172	CcSEcCtD
Floxuridine—Discomfort—Prednisone—multiple sclerosis	6.28e-05	0.00172	CcSEcCtD
Floxuridine—Erythema—Methotrexate—multiple sclerosis	6.24e-05	0.00171	CcSEcCtD
Floxuridine—Hypersensitivity—Prednisolone—multiple sclerosis	6.18e-05	0.00169	CcSEcCtD
Floxuridine—Body temperature increased—Triamcinolone—multiple sclerosis	6.1e-05	0.00167	CcSEcCtD
Floxuridine—Anaphylactic shock—Prednisone—multiple sclerosis	6.09e-05	0.00167	CcSEcCtD
Floxuridine—Abdominal pain—Methylprednisolone—multiple sclerosis	6.08e-05	0.00167	CcSEcCtD
Floxuridine—Decreased appetite—Betamethasone—multiple sclerosis	6.08e-05	0.00167	CcSEcCtD
Floxuridine—Decreased appetite—Dexamethasone—multiple sclerosis	6.08e-05	0.00167	CcSEcCtD
Floxuridine—Nausea—Mitoxantrone—multiple sclerosis	6.07e-05	0.00166	CcSEcCtD
Floxuridine—Infection—Prednisone—multiple sclerosis	6.05e-05	0.00166	CcSEcCtD
Floxuridine—TYMS—Clobetasol propionate—Methylprednisolone—multiple sclerosis	6.05e-05	0.0315	CbGdCrCtD
Floxuridine—Nervous system disorder—Prednisone—multiple sclerosis	5.98e-05	0.00164	CcSEcCtD
Floxuridine—TYMS—Flunisolide—Methylprednisolone—multiple sclerosis	5.97e-05	0.0311	CbGdCrCtD
Floxuridine—TYMS—Clobetasol propionate—Betamethasone—multiple sclerosis	5.95e-05	0.031	CbGdCrCtD
Floxuridine—TYMS—Clobetasol propionate—Dexamethasone—multiple sclerosis	5.95e-05	0.031	CbGdCrCtD
Floxuridine—TYMS—Triamcinolone—Methylprednisolone—multiple sclerosis	5.91e-05	0.0308	CbGdCrCtD
Floxuridine—TYMS—Flunisolide—Betamethasone—multiple sclerosis	5.88e-05	0.0306	CbGdCrCtD
Floxuridine—TYMS—Flunisolide—Dexamethasone—multiple sclerosis	5.88e-05	0.0306	CbGdCrCtD
Floxuridine—TYMS—Clobetasol propionate—Triamcinolone—multiple sclerosis	5.82e-05	0.0303	CbGdCrCtD
Floxuridine—TYMS—Triamcinolone—Betamethasone—multiple sclerosis	5.82e-05	0.0303	CbGdCrCtD
Floxuridine—TYMS—Triamcinolone—Dexamethasone—multiple sclerosis	5.82e-05	0.0303	CbGdCrCtD
Floxuridine—Anorexia—Prednisone—multiple sclerosis	5.81e-05	0.00159	CcSEcCtD
Floxuridine—Ill-defined disorder—Methotrexate—multiple sclerosis	5.79e-05	0.00159	CcSEcCtD
Floxuridine—Anaemia—Methotrexate—multiple sclerosis	5.77e-05	0.00158	CcSEcCtD
Floxuridine—Feeling abnormal—Betamethasone—multiple sclerosis	5.77e-05	0.00158	CcSEcCtD
Floxuridine—Feeling abnormal—Dexamethasone—multiple sclerosis	5.77e-05	0.00158	CcSEcCtD
Floxuridine—TYMS—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	5.76e-05	0.03	CbGdCrCtD
Floxuridine—TYMS—Flunisolide—Triamcinolone—multiple sclerosis	5.74e-05	0.0299	CbGdCrCtD
Floxuridine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	5.72e-05	0.00157	CcSEcCtD
Floxuridine—Gastrointestinal pain—Betamethasone—multiple sclerosis	5.72e-05	0.00157	CcSEcCtD
Floxuridine—Hypersensitivity—Triamcinolone—multiple sclerosis	5.68e-05	0.00156	CcSEcCtD
Floxuridine—TYMS—Fluticasone Propionate—Dexamethasone—multiple sclerosis	5.67e-05	0.0295	CbGdCrCtD
Floxuridine—TYMS—Fluticasone Propionate—Betamethasone—multiple sclerosis	5.67e-05	0.0295	CbGdCrCtD
Floxuridine—Hypersensitivity—Methylprednisolone—multiple sclerosis	5.67e-05	0.00155	CcSEcCtD
Floxuridine—TYMS—brain—multiple sclerosis	5.66e-05	0.0566	CbGeAlD
Floxuridine—Malaise—Methotrexate—multiple sclerosis	5.63e-05	0.00154	CcSEcCtD
Floxuridine—Leukopenia—Methotrexate—multiple sclerosis	5.59e-05	0.00153	CcSEcCtD
Floxuridine—TYMS—Fluticasone Propionate—Triamcinolone—multiple sclerosis	5.54e-05	0.0289	CbGdCrCtD
Floxuridine—Asthenia—Triamcinolone—multiple sclerosis	5.53e-05	0.00151	CcSEcCtD
Floxuridine—Abdominal pain—Dexamethasone—multiple sclerosis	5.53e-05	0.00151	CcSEcCtD
Floxuridine—Abdominal pain—Betamethasone—multiple sclerosis	5.53e-05	0.00151	CcSEcCtD
Floxuridine—Body temperature increased—Betamethasone—multiple sclerosis	5.53e-05	0.00151	CcSEcCtD
Floxuridine—Body temperature increased—Dexamethasone—multiple sclerosis	5.53e-05	0.00151	CcSEcCtD
Floxuridine—Asthenia—Methylprednisolone—multiple sclerosis	5.52e-05	0.00151	CcSEcCtD
Floxuridine—TYMS—Clobetasol propionate—Prednisone—multiple sclerosis	5.52e-05	0.0288	CbGdCrCtD
Floxuridine—TYMS—Flunisolide—Prednisone—multiple sclerosis	5.45e-05	0.0284	CbGdCrCtD
Floxuridine—TYMS—Diflorasone—Methylprednisolone—multiple sclerosis	5.45e-05	0.0284	CbGdCrCtD
Floxuridine—TYMS—Triamcinolone—Prednisone—multiple sclerosis	5.39e-05	0.0281	CbGdCrCtD
Floxuridine—TYMS—Clobetasol propionate—Prednisolone—multiple sclerosis	5.39e-05	0.0281	CbGdCrCtD
Floxuridine—TYMS—Diflorasone—Dexamethasone—multiple sclerosis	5.36e-05	0.0279	CbGdCrCtD
Floxuridine—TYMS—Diflorasone—Betamethasone—multiple sclerosis	5.36e-05	0.0279	CbGdCrCtD
Floxuridine—TYMS—Flunisolide—Prednisolone—multiple sclerosis	5.32e-05	0.0277	CbGdCrCtD
Floxuridine—Decreased appetite—Prednisone—multiple sclerosis	5.3e-05	0.00145	CcSEcCtD
Floxuridine—Rash—Prednisolone—multiple sclerosis	5.29e-05	0.00145	CcSEcCtD
Floxuridine—Dermatitis—Prednisolone—multiple sclerosis	5.28e-05	0.00145	CcSEcCtD
Floxuridine—Diarrhoea—Methylprednisolone—multiple sclerosis	5.26e-05	0.00144	CcSEcCtD
Floxuridine—TYMS—Triamcinolone—Prednisolone—multiple sclerosis	5.26e-05	0.0274	CbGdCrCtD
Floxuridine—Headache—Prednisolone—multiple sclerosis	5.25e-05	0.00144	CcSEcCtD
Floxuridine—Discomfort—Methotrexate—multiple sclerosis	5.25e-05	0.00144	CcSEcCtD
Floxuridine—TYMS—Diflorasone—Triamcinolone—multiple sclerosis	5.24e-05	0.0273	CbGdCrCtD
Floxuridine—Confusional state—Methotrexate—multiple sclerosis	5.13e-05	0.00141	CcSEcCtD
Floxuridine—Anaphylactic shock—Methotrexate—multiple sclerosis	5.09e-05	0.00139	CcSEcCtD
Floxuridine—Infection—Methotrexate—multiple sclerosis	5.06e-05	0.00139	CcSEcCtD
Floxuridine—Feeling abnormal—Prednisone—multiple sclerosis	5.02e-05	0.00137	CcSEcCtD
Floxuridine—Asthenia—Dexamethasone—multiple sclerosis	5.02e-05	0.00137	CcSEcCtD
Floxuridine—Asthenia—Betamethasone—multiple sclerosis	5.02e-05	0.00137	CcSEcCtD
Floxuridine—Nervous system disorder—Methotrexate—multiple sclerosis	4.99e-05	0.00137	CcSEcCtD
Floxuridine—Thrombocytopenia—Methotrexate—multiple sclerosis	4.99e-05	0.00137	CcSEcCtD
Floxuridine—Gastrointestinal pain—Prednisone—multiple sclerosis	4.98e-05	0.00136	CcSEcCtD
Floxuridine—Nausea—Prednisolone—multiple sclerosis	4.98e-05	0.00136	CcSEcCtD
Floxuridine—TYMS—Diflorasone—Prednisone—multiple sclerosis	4.97e-05	0.0259	CbGdCrCtD
Floxuridine—Vomiting—Triamcinolone—multiple sclerosis	4.9e-05	0.00134	CcSEcCtD
Floxuridine—Vomiting—Methylprednisolone—multiple sclerosis	4.89e-05	0.00134	CcSEcCtD
Floxuridine—Rash—Triamcinolone—multiple sclerosis	4.86e-05	0.00133	CcSEcCtD
Floxuridine—Dermatitis—Triamcinolone—multiple sclerosis	4.86e-05	0.00133	CcSEcCtD
Floxuridine—Anorexia—Methotrexate—multiple sclerosis	4.85e-05	0.00133	CcSEcCtD
Floxuridine—TYMS—Diflorasone—Prednisolone—multiple sclerosis	4.85e-05	0.0253	CbGdCrCtD
Floxuridine—Rash—Methylprednisolone—multiple sclerosis	4.85e-05	0.00133	CcSEcCtD
Floxuridine—Dermatitis—Methylprednisolone—multiple sclerosis	4.85e-05	0.00133	CcSEcCtD
Floxuridine—Headache—Triamcinolone—multiple sclerosis	4.83e-05	0.00132	CcSEcCtD
Floxuridine—Headache—Methylprednisolone—multiple sclerosis	4.82e-05	0.00132	CcSEcCtD
Floxuridine—Abdominal pain—Prednisone—multiple sclerosis	4.82e-05	0.00132	CcSEcCtD
Floxuridine—Body temperature increased—Prednisone—multiple sclerosis	4.82e-05	0.00132	CcSEcCtD
Floxuridine—Diarrhoea—Betamethasone—multiple sclerosis	4.79e-05	0.00131	CcSEcCtD
Floxuridine—Diarrhoea—Dexamethasone—multiple sclerosis	4.79e-05	0.00131	CcSEcCtD
Floxuridine—TYMS—Budesonide—Methylprednisolone—multiple sclerosis	4.77e-05	0.0249	CbGdCrCtD
Floxuridine—TYMS—Budesonide—Dexamethasone—multiple sclerosis	4.7e-05	0.0245	CbGdCrCtD
Floxuridine—TYMS—Budesonide—Betamethasone—multiple sclerosis	4.7e-05	0.0245	CbGdCrCtD
Floxuridine—TYMS—Budesonide—Triamcinolone—multiple sclerosis	4.59e-05	0.0239	CbGdCrCtD
Floxuridine—Nausea—Triamcinolone—multiple sclerosis	4.58e-05	0.00125	CcSEcCtD
Floxuridine—Nausea—Methylprednisolone—multiple sclerosis	4.57e-05	0.00125	CcSEcCtD
Floxuridine—Hypersensitivity—Prednisone—multiple sclerosis	4.49e-05	0.00123	CcSEcCtD
Floxuridine—Vomiting—Betamethasone—multiple sclerosis	4.45e-05	0.00122	CcSEcCtD
Floxuridine—Vomiting—Dexamethasone—multiple sclerosis	4.45e-05	0.00122	CcSEcCtD
Floxuridine—Decreased appetite—Methotrexate—multiple sclerosis	4.43e-05	0.00121	CcSEcCtD
Floxuridine—Rash—Dexamethasone—multiple sclerosis	4.41e-05	0.00121	CcSEcCtD
Floxuridine—Rash—Betamethasone—multiple sclerosis	4.41e-05	0.00121	CcSEcCtD
Floxuridine—Dermatitis—Dexamethasone—multiple sclerosis	4.41e-05	0.00121	CcSEcCtD
Floxuridine—Dermatitis—Betamethasone—multiple sclerosis	4.41e-05	0.00121	CcSEcCtD
Floxuridine—Headache—Dexamethasone—multiple sclerosis	4.38e-05	0.0012	CcSEcCtD
Floxuridine—Headache—Betamethasone—multiple sclerosis	4.38e-05	0.0012	CcSEcCtD
Floxuridine—Asthenia—Prednisone—multiple sclerosis	4.37e-05	0.0012	CcSEcCtD
Floxuridine—TYMS—Budesonide—Prednisone—multiple sclerosis	4.36e-05	0.0227	CbGdCrCtD
Floxuridine—TYMS—Budesonide—Prednisolone—multiple sclerosis	4.25e-05	0.0222	CbGdCrCtD
Floxuridine—Feeling abnormal—Methotrexate—multiple sclerosis	4.2e-05	0.00115	CcSEcCtD
Floxuridine—TYMS—Danazol—Prednisone—multiple sclerosis	4.18e-05	0.0218	CbGdCrCtD
Floxuridine—Diarrhoea—Prednisone—multiple sclerosis	4.17e-05	0.00114	CcSEcCtD
Floxuridine—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.16e-05	0.00114	CcSEcCtD
Floxuridine—Nausea—Betamethasone—multiple sclerosis	4.16e-05	0.00114	CcSEcCtD
Floxuridine—Nausea—Dexamethasone—multiple sclerosis	4.16e-05	0.00114	CcSEcCtD
Floxuridine—Abdominal pain—Methotrexate—multiple sclerosis	4.03e-05	0.0011	CcSEcCtD
Floxuridine—Body temperature increased—Methotrexate—multiple sclerosis	4.03e-05	0.0011	CcSEcCtD
Floxuridine—Vomiting—Prednisone—multiple sclerosis	3.87e-05	0.00106	CcSEcCtD
Floxuridine—Rash—Prednisone—multiple sclerosis	3.84e-05	0.00105	CcSEcCtD
Floxuridine—Dermatitis—Prednisone—multiple sclerosis	3.84e-05	0.00105	CcSEcCtD
Floxuridine—Headache—Prednisone—multiple sclerosis	3.82e-05	0.00105	CcSEcCtD
Floxuridine—Hypersensitivity—Methotrexate—multiple sclerosis	3.75e-05	0.00103	CcSEcCtD
Floxuridine—Asthenia—Methotrexate—multiple sclerosis	3.65e-05	0.001	CcSEcCtD
Floxuridine—Nausea—Prednisone—multiple sclerosis	3.62e-05	0.000991	CcSEcCtD
Floxuridine—Diarrhoea—Methotrexate—multiple sclerosis	3.48e-05	0.000954	CcSEcCtD
Floxuridine—Vomiting—Methotrexate—multiple sclerosis	3.24e-05	0.000887	CcSEcCtD
Floxuridine—Rash—Methotrexate—multiple sclerosis	3.21e-05	0.000879	CcSEcCtD
Floxuridine—Dermatitis—Methotrexate—multiple sclerosis	3.21e-05	0.000878	CcSEcCtD
Floxuridine—Headache—Methotrexate—multiple sclerosis	3.19e-05	0.000873	CcSEcCtD
Floxuridine—Nausea—Methotrexate—multiple sclerosis	3.02e-05	0.000828	CcSEcCtD
